Mississippi Medical Cannabis Qualifying Conditions

Mississippi’s list under Miss. Code Ann. § 41-137-3 covers roughly 22 named conditions plus several symptom-based pathways. Per MSDH’s January 2026 report, chronic pain and PTSD remain the most common qualifying conditions; Type 2 diabetes with neurological complications is also rising.

Last verified: May 2026

The Statute

Under Miss. Code Ann. § 41-137-3, a "debilitating medical condition" is defined to include the named conditions and symptom pathways below. To qualify for an MMCP card, a Mississippi resident must have at least one named condition or a qualifying symptom pathway tied to a chronic, terminal, or debilitating disease, certified by a Mississippi-licensed practitioner registered with MSDH.

Named Qualifying Conditions

  • Cancer
  • Parkinson’s disease
  • Huntington’s disease
  • Muscular dystrophy
  • Glaucoma
  • Spastic quadriplegia
  • HIV / AIDS
  • Hepatitis
  • Amyotrophic lateral sclerosis (ALS)
  • Crohn’s disease
  • Ulcerative colitis
  • Sickle-cell anemia
  • Alzheimer’s disease
  • Dementia
  • Post-traumatic stress disorder (PTSD)
  • Autism
  • Pain that is unresponsive to opioid management
  • Diabetic / peripheral neuropathy
  • Spinal cord disease or severe spinal cord injury

Symptom-Based Pathways

In addition to a named condition, a patient qualifies if they have a chronic, terminal, or debilitating disease that produces:

  • Cachexia or wasting syndrome
  • Chronic pain
  • Severe or intractable nausea
  • Seizures
  • Severe and persistent muscle spasms (including, but not limited to, those characteristic of multiple sclerosis)

The symptom pathways act as a backup — a patient with a qualifying symptom can certify even if their underlying disease is not on the named list, provided the disease itself is chronic, terminal, or debilitating.

Miss. Code Ann. § 41-137-3 defines the qualifying medical conditions for the Mississippi Medical Cannabis Program.

Mississippi Code — Title 41 Chapter 137

Most-Used Pathways in Practice

Per MSDH’s January 2026 report, chronic pain and PTSD remain the most common qualifying conditions. The MSDH report also notes that "Type 2 diabetes with neurological complications is also on the rise as a qualifying condition." The pain pathway is broadest because it covers the largest patient population (older adults with osteoarthritis, back injury, fibromyalgia, etc.). The PTSD pathway has grown post-Camp Shelby and post-Keesler AFB veteran enrollment, particularly in Hattiesburg and the Gulf Coast.

The Opioid-First Rule for Pain Patients

SB 2095 added a unique requirement for chronic-pain patients: they must try opioids first before qualifying for medical cannabis as treatment for pain. This was a political compromise designed to address opioid-crisis concerns. In practice it is a documentation hurdle, not a permanent bar — the certifying practitioner documents a trial of opioid management and the inadequacy of response, and the patient qualifies under "pain that is unresponsive to opioid management."

Younger Adults (18–25)

Patients between 18 and 25 must obtain certifications from two different practitioners at separate medical practices, with one being an MD or DO. Minors must have a custodial parent or legal guardian as caregiver and may only be certified by an MD or DO. These additional safeguards reflect SB 2095’s political compromise around younger-patient access.

Adding New Qualifying Conditions

Under Miss. Code Ann. § 41-137-17, Mississippi residents may petition MSDH to add new qualifying conditions; the agency must approve or deny within 60 days. The petition mechanism has produced limited additions. Reform advocates have long argued for a more flexible "Right to Try" pathway — this was the core of HB 1152 (2026), which passed the Senate 34–17 and the House 104–7 before being vetoed by Gov. Reeves on March 26, 2026. See Reeves vetoes page.

What Is NOT on the List

  • Anxiety disorders (general, social, panic) — not listed; some patients may qualify under PTSD where a documented trauma history exists
  • ADHD
  • Depression as a stand-alone diagnosis
  • Insomnia
  • Migraines
  • Opioid use disorder / addiction (not listed; the pain pathway covers opioid-refractory pain)

The Access Gap

As of August 2025, MMCP reform advocates flagged that 35 of Mississippi’s 82 counties had no certified medical cannabis practitioner — a significant access gap, particularly in the Delta and Pine Belt. A patient in such a county must travel to Jackson, Hattiesburg, Oxford, Tupelo, Gulfport, or another hub with a certified practitioner. Practitioner networks like Pause Pain & Wellness and Magnolia Cannabis Clinics operate statewide locations specifically to address this gap.

For Research-Backed Information

For evidence-based summaries on how cannabis may affect specific conditions, see TryCannabis.org’s conditions guide. Always consult your treating physician.

Next Steps